COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms

Marek Ostaszewski*, Anna Niarakis, Alexander Mazein, Inna Kuperstein, Robert Phair, Aurelio Orta-Resendiz, Vidisha Singh, Sara Sadat Aghamiri, Marcio Luis Acencio, Enrico Glaab, Andreas Ruepp, Gisela Fobo, Corinna Montrone, Barbara Brauner, Goar Frishman, Luis Cristóbal Monraz Gómez, Julia Somers, Matti Hoch, Shailendra Kumar Gupta, Julia ScheelHanna Borlinghaus, Tobias Czauderna, Falk Schreiber, Arnau Montagud, Miguel Ponce de Leon, Akira Funahashi, Yusuke Hiki, Noriko Hiroi, Takahiro G Yamada, Andreas Dräger, Alina Renz, Muhammad Naveez, Zsolt Bocskei, Francesco Messina, Daniela Börnigen, Liam Fergusson, Marta Conti, Marius Rameil, Vanessa Nakonecnij, Jakob Vanhoefer, Leonard Schmiester, Muying Wang, Martina Kutmon, Susan Coort, Lars Eijssen, Friederike Ehrhart, Denise Slenter, Marvin Martens, Nhung Pham, Chris T Evelo, COVID-19 Disease Map Community

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

We need to effectively combine the knowledge from surging literature with complex datasets to propose mechanistic models of SARS-CoV-2 infection, improving data interpretation and predicting key targets of intervention. Here, we describe a large-scale community effort to build an open access, interoperable and computable repository of COVID-19 molecular mechanisms. The COVID-19 Disease Map (C19DMap) is a graphical, interactive representation of disease-relevant molecular mechanisms linking many knowledge sources. Notably, it is a computational resource for graph-based analyses and disease modelling. To this end, we established a framework of tools, platforms and guidelines necessary for a multifaceted community of biocurators, domain experts, bioinformaticians and computational biologists. The diagrams of the C19DMap, curated from the literature, are integrated with relevant interaction and text mining databases. We demonstrate the application of network analysis and modelling approaches by concrete examples to highlight new testable hypotheses. This framework helps to find signatures of SARS-CoV-2 predisposition, treatment response or prioritisation of drug candidates. Such an approach may help deal with new waves of COVID-19 or similar pandemics in the long-term perspective.

Original languageEnglish
Article numbere10387
Number of pages22
JournalMolecular Systems Biology
Volume17
Issue number10
DOIs
Publication statusPublished - Oct 2021

Keywords

  • BETA
  • CORONAVIRUS
  • DEGRADATION
  • ENVIRONMENT
  • EXPRESSION
  • INTERFERON SIGNALING PATHWAY
  • NF-KAPPA-B
  • SARS-COV
  • SARS-COV-2
  • SPIKE PROTEIN
  • computable knowledge repository
  • large-scale biocuration
  • omics data analysis
  • open access community effort
  • systems biomedicine

Cite this